Investing.com - BIO-Key reported on Monday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
BIO-Key announced earnings per share of $-0.290 on revenue of $1.37M. Analysts polled by Investing.com anticipated EPS of $-0.160 on revenue of $2.4M.
BIO-Key shares are down 20% from the beginning of the year and are trading at $1.560 , down-from-52-week-high.
BIO-Key follows other major Information Technology sector earnings this month
BIO-Key's report follows an earnings beat by Apple on Thursday, October 27, 2022, who reported EPS of $1.29 on revenue of $90.1B, compared to forecasts EPS of $1.26 on revenue of $88.76B.
Microsoft had beat expectations on Tuesday, October 25, 2022 with first quarter EPS of $2.35 on revenue of $50.1B, compared to forecast for EPS of $2.32 on revenue of $49.86B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar